Pharmacological activities of anti-hypertensive drug delivery through a transdermal patch – a brief review
DOI:
https://doi.org/10.61114/UJPSR.8.2.2022.1-7Keywords:
Transdermal drug delivery systems, Transdermal patches, Antihypertensive drugsAbstract
One of the methods falling under the category of controlled drug delivery is the transdermal drug delivery system (TDDS), which is designed to distribute the medicine via the skin at a predefined and regulated pace. Hypertension is one of the largest death-causing diseases in mankind. Since it is a chronic disease, it required continuous treatment. The disadvantages of antihypertensive drugs such as more frequent administration, extensive first-pass metabolism and variable bioavailability, making them an ideal candidate for transdermal drug delivery systems. This article is dedicated to reviewing antihypertensive transdermal patches from the perspective of enhancing bioavailability and improving patient compliance. The various antihypertensive drugs considered in the review include timolol maleate, nicardipine hydrochloride, captopril, verapamil hydrochloride, nifedipine, propranolol hydrochloride, diltiazem hydrochloride, amlodipine besilate and carvedilol. Clonidine was the first antihypertensive drug developed in the transdermal form. Recently, various antihypertensive transdermal patches are available in the pharmaceutical market. Most of the reported methods in the literature employed the solvent evaporation method or solvent casting method for the preparation of transdermal patches. Depending on the release required over some time, the concentrations of polymer, plasticizer and penetrant were varied.
References
Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004;3:115–24. https://doi.org/10.1038/nrd1304.
Dolnicar S, Chapple A, Trees AJ "ANGIOSTRONGYLUS-VINDINW. VR 120. 1. (1987): 424-424. (1987): 424-424. (1987): 424-424., Team RC, Mobley CD, Fenkçi IV, Maternal Fizyoloji. “Çiçek MN, Ed.” Kadın Hastalıkları ve Doğum Bilgisi, Öncü Basımevi A (2004): 161-9., et al. Scholar (4). Why We Need J Interact Advert 1997;3:45.
Tanwar H, Jambheshwar G. Transdermal Drug Delivery System: A Review Himanshi Tanwar And Ruchika Sachdeva Guru Jambheshwar University Of Science & Technology, Hisar, Haryana, India. Int J Pharm Sci Res 2016;7:2274–90. https://doi.org/10.13040/IJPSR.0975-8232.7(6).2274-90.
Selvam R, Singh A, Sivakumar T. Transdermal drug delivery systems for antihypertensive drugs-A review. Int J Pharm Biomed Res 2010;1:1–8.
Alderman MH. Hypertension Control: Improved, but not enough! Am J Hypertens 2007;20:347. https://doi.org/10.1016/j.amjhyper.2007.02.002.
Casavant MJ. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. vol. 288. 2002. https://doi.org/10.1001/jama.288.16.2052.
Mehta R. Topical and Transdermal Drug Delivery : What a Pharmacist Needs to Know 2004:1–10.
Cocolas GH. American Journal of Pharmaceutical Education. Encycl Clin Pharm 2002;70:50–50. https://doi.org/10.3109/9780824706081.011.
Anatomy of Human Skin
https://www.stanfordchildrens.org/en/topic/default?id=anatomy-of-the-skin-85-P01336
Yus, Bruns a, Turnbull CHS and D, Dolnicar S, Chapple A, Adorno T, et al. Scholar 9. Mass Commun Soc 1974;10:349–83.
Bruns a, Turnbull CHS and D, Dolnicar S, Chapple A, Adorno T, Horkheimer M, et al. Scholar (10). Mass Commun Soc 1974;3:349–83. https://doi.org/10.1163/_q3_SIM_00374.
Turnbull CHS, D., Dolnicar S, Chapple A, Adorno T, Horkheimer M, et al. Scholar (11). Why We Need J Interact Advert 2004;10:349–83. https://doi.org/10.1163/_q3_SIM_00374.
Benson H. Transdermal Drug Delivery: Penetration Enhancement Techniques. Curr Drug Deliv 2005; 2: 23–33. https://doi.org/10.2174/1567201052772915.
Guy RH, Hadgraft J, Bucks DAW. Transdermal drug delivery and cutaneous metabolism. Xenobiotica 1987;17:325–43. https://doi.org/10.3109/00498258709043943.
Oscier C, Bosley N, Milner Q. Scholar (13). Updat Anaesth 2008;24:112–4.
Soni A, Dua JS, Prasad DN. Article Reviewing Transdermal Drug Delivery System. J Drug Deliv Ther 2022;12:176–80. https://doi.org/10.22270/jddt.v12i1.5159.
Leckenby J, Li H. Scholar (14) 1997.
Jensen, G. R., Solberg, D. P., & Zorn TS. Scholar (15) 1992.
Saravanakumar K, Swapna P, Nagaveni P, Vani P, Pujitha K. Transdermal drug delivery system: A review. J Glob Trends Pharm Sci 2015;6:2485–90. https://doi.org/10.22270/ijmspr.v4i1.21.
Neilson B, Rossiter N. Scholar (16). From Precarity to Precariousness Back Again Labour, Life Unstable Networks 2005:5.
Reader, T. W., Flin, R., Mearns, K., & Cuthbertson BH. Scholar (17) 2009.
Singh D, Saraf S, Dixit VK, Saraf S. Formulation optimization of gentamicin loaded Eudragit RS100 microspheres using factorial design study. Biol Pharm Bull 2008;31:662–7. https://doi.org/10.1248/bpb.31.662.
El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. Eur J Pharm Biopharm 2011;77:43–55. https://doi.org/10.1016/j.ejpb.2010.10.011.
Novi SB PW (2018). Scholar (19) 2018.
Vats V, Yadav SP, Grover JK. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in rats' glycogen content and carbohydrate metabolism. J Ethnopharmacol 2004;90:155–60. https://doi.org/10.1016/j.jep.2003.09.034.
Aboofazeli R, Zia H, Needham T. Transdermal delivery of nicardipine: An approach to in vitro permeation enhancement. Drug Deliv J Deliv Target Ther Agents 2002;9:239–47. https://doi.org/10.1080/10717540260397855.
Krishnaiah YSR, Satyanarayana V, Bhaskar P. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int J Pharm 2002;247:91–102. https://doi.org/10.1016/S0378-5173(02)00401-5.
Nur AO, Zhang JS. Recent progress in sustained/controlled oral delivery of captopril: An overview. Int J Pharm 2000;194:139–46. https://doi.org/10.1016/S0378-5173(99)00362-2.
Zhou XH, Li Wan Po A. Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine. Biochem Pharmacol 1994;47:1121–6. https://doi.org/10.1016/0006-2952(94)90382-4.
Rastogi V, Upadhyay PP. A Brief View On Antihypertensive Drugs Delivery Through Transdermal Patches. Int J Pharm Sci Res 2012;3:1955–70.
Pratibha C, Vilegave K, dantul brijesh. Analytical Methods, Preformulation Study and Physicochemical Evaluation Techniques for Transdermal Patches of Antihypertensive Drug 2013.
Rama Rao P, Diwan P V. Permeability studies of cellulose acetate free films for transdermal use: Influence of plasticizers. Pharm Acta Helv 1997;72:47–51. https://doi.org/10.1016/S0031-6865(96)00060-X.
Satturwar PM, Fulzele S V., Dorle AK. Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: A technical note. AAPS PharmSciTech 2005;6:649–54. https://doi.org/10.1208/pt060481.
Goodman L. Agilman 1998:1–25.
Ramkanth S, Chetty CM, Sudhakar Y. Transdermal Delivery of Beta Blockers - A novel therapeutic approach for cardiovascular disease 2011;1:186–92.
Kusum Devi V, Saisivam S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion-controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm 2003;29:495–503. https://doi.org/10.1081/DDC-120018638.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Arif Mahammad, Sumit Sinha Mahapatra, Sudip Das, Sanjib Bahadur
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
+91-8349444385,
+91-8670408670,
